Join
Live feed
·
PRReleasevia Quantisnow
Hercules Capital Inc. logo

Beren Therapeutics Secures $300M Financing to Support the Potential Commercial Launch of Adrabetadex and Long-Term Care Initiatives for Infantile-Onset Niemann-Pick Disease, Type C

ByQuantisnow·Wall Street's wire, on your screen.
HTGC· Hercules Capital Inc.
Finance

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HTGC (Hercules Capital Inc.) and more on Quantisnow.